Associazione Qol-one Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT02912208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now